“…[7][8][9][10][11][12][13][14][15]17,[21][22][23] Continuous glucose monitoring performance often was reported to be poor in the low glucose range. 8,10,12,17,19,23 For G4, however, the MARD was only slightly worse (i.e., higher) than in the other concentration ranges, and it was markedly lower than that of other CGM devices. 8,13,17,27 When compared with three CGM systems investigated in a very similar setting [the G4's predecessor SEVEN ® Plus system (Dexcom, San Diego, CA), FreeStyle Navigator™ (Abbott Diabetes Care, Alameda, CA), and Guardian ® REAL-Time (Medtronic MiniMed, Northridge, CA)], 27 an improved performance can be noted.…”